BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31152111)

  • 1. High α B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer.
    Tan L; Sha L; Hou N; Zhang M; Ma Q; Shi C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31152111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.
    Volkmann J; Reuning U; Rudelius M; Häfner N; Schuster T; Becker V Ros A; Weimer J; Hilpert F; Kiechle M; Dürst M; Arnold N; Schmalfeldt B; Meindl A; Ramser J
    Int J Cancer; 2013 Jun; 132(12):2820-32. PubMed ID: 23225306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Alpha B-crystallin expression and prognosis in patients with solid tumors: A protocol for systematic review and meta-analysis.
    Yang M; Li Y; Tian F
    Medicine (Baltimore); 2021 Feb; 100(7):e24831. PubMed ID: 33607849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha B-crystallin correlates with poor survival in colorectal cancer.
    Shi C; He Z; Hou N; Ni Y; Xiong L; Chen P
    Int J Clin Exp Pathol; 2014; 7(9):6056-63. PubMed ID: 25337251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
    Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
    Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer.
    Sagarra RA; Andrade LA; Martinez EZ; Pinto GA; Syrjänen KJ; Derchain SF
    Int J Gynecol Cancer; 2002; 12(6):720-7. PubMed ID: 12445249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer.
    Qin H; Ni Y; Tong J; Zhao J; Zhou X; Cai W; Liang J; Yao X
    Med Oncol; 2014 Aug; 31(8):142. PubMed ID: 25048725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEF6 expression in ovarian carcinoma correlates with poor patient survival.
    Liew PL; Fang CY; Lee YC; Lee YC; Chen CL; Chu JS
    Diagn Pathol; 2016 Aug; 11(1):68. PubMed ID: 27488395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Qiao C; Liu G; Zhou H; Liu Q
    J Cell Mol Med; 2018 Jun; 22(6):3215-3222. PubMed ID: 29566309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 12. High expression of sperm-associated antigen 5 correlates with poor survival in ovarian cancer.
    Zhang M; Sha L; Hou N; Shi C; Tan L
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31985007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53, Mismatch Repair Protein, and POLE Abnormalities in Ovarian Clear Cell Carcinoma: An Outcome-based Clinicopathologic Analysis.
    Parra-Herran C; Bassiouny D; Lerner-Ellis J; Olkhov-Mitsel E; Ismiil N; Hogen L; Vicus D; Nofech-Mozes S
    Am J Surg Pathol; 2019 Dec; 43(12):1591-1599. PubMed ID: 31335355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CRYAB with the angiogenesis and poor prognosis for human gastric cancer.
    Tao X; Cheng L; Li Y; Ci H; Xu J; Wu S; Tao Y
    Medicine (Baltimore); 2019 Nov; 98(45):e17799. PubMed ID: 31702632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
    Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
    Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.
    Skírnisdóttir I; Seidal T; Sorbe B
    Int J Gynecol Cancer; 2004; 14(2):259-70. PubMed ID: 15086725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUCKS nuclear elevated expression indicates progression and prognosis of ovarian cancer.
    Shi C; Qin L; Gao H; Gu L; Yang C; Liu H; Liu T
    Tumour Biol; 2017 Sep; 39(9):1010428317714631. PubMed ID: 28877654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.